Lung cancer in HIV-infected patients

International Journal of STD and AIDS

Volumn 25, Issue 4, 2014, Pages 239-243

  Palacios, Rosario ^a,b   Pascual, Javier ^a   Cabrera, Eva ^a   Lebrón, Jose M ^c   Guerrero León, Miguel A ^d   del Arco, Alfonso ^c   Colmenero, Juan D ^b,d   Santos, Jesús ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina IBIMA Plataforma Bionand   (Spain)

^c HOSPITAL COSTA DEL SOL   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

AIDS; HIV; lung cancer; malignancies

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG ADENOCARCINOMA; LUNG INFECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OBSERVATIONAL STUDY; POPULATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SPAIN; VIRUS LOAD;

AIDS; HIV; LUNG CANCER; MALIGNANCIES;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SOCIOECONOMIC FACTORS; SPAIN; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; VIRAL LOAD;

EID: 84895828314     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413499317     Document Type: Article

References (26)

1. Parkin DM,Bray F,Ferlay J, et al.Global cancer statistics, 2002.CA Cancer J Clin. 2005;55:74-108.
2. Salmerón D,Chirlaque MD,Isabel Izarzugaza M, et al.Lung cancer prognosis in Spain: the role of histology, age and sex.Respir Med. 2012;106:1301-1308.
3. Shiels MS,Pfeiffer RM,Gail MH, et al.Cancer burden in the HIV-infected population in the United States.J Natl Cancer Inst. 2011;103:753-762.
4. Engels EA,Goedert JJ.Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.J Natl Cancer Inst. 2005;97:407-409.
5. Engels EA,Pfeiffer RM,Goedert JJ,/ HIV, et al.Cancer Match Study AIDS,Trends in cancer risk among people with AIDS in the United States 1980-2002.AIDS. 2006;20:1645-1654.
6. Santos J,Palacios R,Ruiz J, et al.Unusual malignant tumours in patients with HIV infection.Int J STD AIDS. 2002;13:674-676.
7. Chaturvedi AK,Pfeiffer RM,Chang L, et al.Elevated risk of lung cancer among people with AIDS.AIDS. 2007;21:207-213.
8. Engels EA,Brock MV,Chen J, et al.Elevated incidence of lung cancer among HIV-infected individuals.J Clin Oncol. 2006;24:1383-1388.
9. Kirk GD,Merlo C,O' Driscoll P, et al.HIV infection is associated with an increased risk for lung cancer, independent of smoking.Clin Infect Dis. 2007;45:103-110.
10. Shiels MS,Cole SR,Mehta SH, et al.Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users.J Acquir Immune Defic Syndr. 2010;55:510-515.
11. Mani D,Haigentz M,Aboulafia DM.Lung cancer in HIV infection.Clin Lung Cancer. 2012;13:6-13.
12. Mocroft A,Ledergerber B,Katlama C, et al.EuroSIDA Study Group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study.Lancet. 2003;362:22-29.
13. Valencia-Ortega ME. Non-AIDS defining malignancies or the sleeping giant: an update. Enferm Infecc Microbiol Clin 2013; 31: 319--327.
14. Simard EP,Engels EA.Cancer as a cause of death among people with AIDS in United States.Clin Infect Dis. 2010;51:957-962.
15. Cadranel J,Gafield D,Lavole A, et al.Lung cancer in HIV infected patients: facts, questions and challenges.Thorax. 2006;61:1000-1008.
16. Clifford GM,Polesel J,Rickenbach M, et al.Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking and highly active antiretroviral therapy.J Natl Cancer Inst. 2005;97:425-432.
17. Sigel K,Wisnivesky J,Gordon K, et al.HIV as an independent risk factor for incident lung cancer.AIDS. 2012;26:1017-1025.
18. Silverberg MJ,Chao C,Leyden WA, et al.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Cancer Epidemiol Biomarkers Prev. 2011;20:2551-2559.
19. Phelps RM,Smith DK,Heilig CM, et al.Cancer incidence in women with or at risk for HIV.Int J Cancer. 2001;94:753-757.
20. Suneja G,Shiels MS,Melvillec SK, et al.Disparities in the treatment and outcomes of lung cancer among HIV-infected people in Texas.AIDS. 2013;27:459-468.
21. Shiels MS,Pfeiffer RM,Engels EA.Age at cancer diagnosis among persons with AIDS in the United States.Ann Inter Med. 2010;153:452-460.
22. Bobba RK,Holly JS,Loy T, et al.Scar carcinoma of the lung: a historical perspective.Clin Lung Cancer. 2011;12:148-154.
23. Silverberg MJ,Chao C,Leyden WA, et al.HIV infection and the risk of cancers with and without a known infectious cause.AIDS. 2009;23:2337-2345.
24. Shebl FM,Engels EA,Goedert JJ, et al.Pulmonary infections and risk of lung cancer among persons with AIDS.J Acquir Immune Defic Syndr. 2010;55:375-379.
25. Rengan R,Mitra N,Liao K, et al.Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.Lancet Oncol. 2012;13:1203-1209.
26. Tammemägi MC,Katki HA,Hocking WG, et al.Selection criteria for lung-cancer screening.N Engl J Med. 2013;368:728-736.